University of California

Uwill's 10 Tips to Improve Your Mental Health This Summer

Retrieved on: 
Tuesday, May 31, 2022
Optimism, Health minister, Mental health, Multimedia, Pleasure, View, University of Michigan, Boston College, LMHC, Depression, University of California, Exercise, Life, Student, Anxiety, Hobby, University, Xavier University, Cognitive behavioral therapy, Friends, NASPA, Emotion, Sleep, Medicine, New York University

BOSTON, May 31, 2022 /PRNewswire/ -- As the end of Mental Health Awareness month is upon us, our focus shifts to how to be well this summer.

Key Points: 
  • BOSTON, May 31, 2022 /PRNewswire/ -- As the end of Mental Health Awareness month is upon us, our focus shifts to how to be well this summer.
  • Erin Andrews, LMHC, an expert in cognitive behavioral therapy who serves as Manager of Clinical Affairs for the leading college mental health solution Uwill, shares 10 tips to improve your mental health this summer.
  • She received her Master's degree in mental health counseling and wellness from New York University.
  • Uwill has been described by mental health advocates as the most effective and cost-efficient way to support students.

Entertainment Lawyer Elsa Ramo of Ramo Law PC Named a Top Woman Lawyer in Southern California

Retrieved on: 
Tuesday, May 31, 2022
Independent Spirit Awards, UCLA, Sylvester Stallone, Variety, Queer Eye, Mentorship, Women in media, Kevin, Private law, Scout Productions, AFI, Leadership, Organic, Women Creating Change, The Jim Henson Company, Lists of academic journals, Universal Pictures, Lawyer, Daily Journal, Associative entity, Balboa Productions, University of California, Industry, Female, Life, American, Imagine Entertainment, University, American Film Institute, Human, Organization, Glass, SXSW, Television, Sex industry, Film, Woman

LOS ANGELES, May 31, 2022 /PRNewswire/ -- Entertainment law firm Ramo Law PC announced today that its Managing Partner Elsa Ramo has been named to the 2022 "Top 100 Women Lawyers" list by the Daily Journal.

Key Points: 
  • LOS ANGELES, May 31, 2022 /PRNewswire/ -- Entertainment law firm Ramo Law PC announced today that its Managing Partner Elsa Ramo has been named to the 2022 "Top 100 Women Lawyers" list by the Daily Journal.
  • The annual list recognizes the most accomplished women attorneys practicing in California.
  • She speaks at educational institutions including the American Film Institute (AFI) and University of California, Los Angeles (UCLA), and on platforms such as Stage32.
  • Additionally, Ramo regularly supports charities advocating for women in the entertainment industry, such as Women in Media, Women Creating Change, Film Fatales, and Film Independent.

Global Impact, on Behalf of the Alliance for Advancing Health Online (AAHO), Shares Research and Announces Upcoming New Program at 75th World Health Assembly

Retrieved on: 
Wednesday, May 25, 2022
Online, MSD, University of California, Institute for Prediction Technology, Global Impact, RFP, Associate professor, Vaccine Confidence Project, Social media, Public health, Â, World, Sabin Vaccine Institute, Vaccine hesitancy, Digital economy, Woman, World Health Organization, Merck & Co., Vaccination, Chatbot, Health, World Health Assembly, Doctor of Science, Associate, Regulation Focused Psychotherapy for Children (RFP-C), Centers for Disease Control and Prevention, Meta, COVID-19, WhatsApp, Merck, University of California, Research, Digital, Tropical medicine, World Bank, Immunization, NJ, Program, University, Technology, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, London School of Hygiene & Tropical Medicine, GLOBE, Pharmaceutical industry, Obstetrics, Fund, Hygiene

The global research is intended to reveal insights on how to harness social media and online engagement to drive vaccine confidence.

Key Points: 
  • The global research is intended to reveal insights on how to harness social media and online engagement to drive vaccine confidence.
  • Global Impact sought proposals that address how social media can be best utilized to better understand vaccine hesitancy and increase vaccination confidence and uptake.
  • Through these partnerships, Global Impact has raised nearly $2 billion for causes such as disaster relief and global development.
  • Global Impacts reach and services are complemented by the work of its subsidiary company, Geneva Global .

Nanoscope Therapeutics Appoints Two Pharmaceutical Industry Veterans as Scientific and Clinical Advisors

Retrieved on: 
Wednesday, May 25, 2022
Department, Chemistry, Retinitis pigmentosa, MBA, Company, University, Dow Medical College, Retina, Doctor of Philosophy, Geographic atrophy, Patient, Genetic testing, Spark Therapeutics, Tufts University School of Medicine, GA, Therapy, BA, Retinal degeneration, MCO, Faculty, D Grubu, ProQR, Corneal transplantation, Novartis, University of California, FDA, AMD, Industry, Harvard University, RP, Medical school, Santen Pharmaceutical, Board, Genentech, Wound healing, Harvard Medical School, Eye, MD, CEO, Pharmaceutical industry, Medical device, Atomic de Broglie microscope, Stargardt disease, Indiana University, Ophthalmology

"We are extremely pleased to have these distinguished leaders join our team of advisors.

Key Points: 
  • "We are extremely pleased to have these distinguished leaders join our team of advisors.
  • "Nanoscope has already begun to demonstrate the tremendous potential of this approach, including extraordinary efficacy and good tolerability in severely visually impaired individuals.
  • At Genentech, Dr. Shams helped to establish the Ophthalmic Clinical R&D Group and led the development of Lucentis through approval.
  • Nanoscope Therapeutics is developing gene-agnostic, sight restoring optogenetic therapies for the millions of patients blinded by retinal degenerative diseases, for which no cure exists.

Manatt Enhances Real Estate and Hospitality Capabilities, Adding Leading Lawyer and Business Adviser

Retrieved on: 
Tuesday, May 24, 2022
Other Professional Services, Other Travel, Legal, Lodging, Destinations, Travel, Consulting, Professional Services, Partner (business rank), Consultant, Opportunity zone, Lawyer, Solution, Real Estate Transaction Standard, Fortune 500, Sociology, LLP, Manatt, Phelps & Phillips, Air Hostess (1933 film), Negotiation, University, Technology, Sale, University of California, Company, Cadwalader, Management, Property management

Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today that Partner Lynn K. Cadwalader has joined its Real Estate Transactions and Finance team in San Francisco, where she will be leading the Firms Hospitality and Leisure practice.

Key Points: 
  • Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today that Partner Lynn K. Cadwalader has joined its Real Estate Transactions and Finance team in San Francisco, where she will be leading the Firms Hospitality and Leisure practice.
  • Lynns deep understanding of the hospitality market, from both a business and legal perspective, and her strength in working creatively with clients to resolve complex issues will be incredibly valuable for our Manatt Real Estate and Manatt Real Estate Advisors teams, and her arrival complements and enhances our existing services within transactions and financings, land use, regulatory, and litigation, arbitration and dispute resolution, said Leader of Manatt Real Estate Michael Polentz .
  • Cadwalader has touched many high-profile hospitality projects around the country and internationally, with work extending from Los Angeles to New York, Latin America and the Middle East.
  • Manatt, Phelps & Phillips, LLP, is a leading professional services firm, providing integrated legal and consulting services to a global client base.

IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast featuring Eric Weisblum, CEO of Silo Pharma Inc.

Retrieved on: 
Wednesday, May 18, 2022
Department, University, Knowledge, Social media, News, University of Texas at Austin, Patient, IBN, Solution, Review, University of California, Interview, Research, Dell Medical School, Behavioural sciences, Securities Act of 1933, Securities Exchange Act of 1934, PTSD, Partnership, Technology, Psychiatry, Therapy, University of Maryland, College Park, Podcast, SEC, Columbia University, OTCQB, Lists of diseases, CEO, GLOBE, Pharmaceutical industry, Management, Public relations, Pharma

The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries.

Key Points: 
  • The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries.
  • Bell2Bells latest podcast features Eric Weisblum, Founder and CEO of Silo Pharma Inc. (OTCQB: SILO ) , a developmental stage biopharmaceutical company.
  • Silo Pharma is focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Parkinsons and other rare neurological disorders, Weisblum said.
  • The latest installment of The Bell2Bell Podcast continues to reinforce IBNs commitment to the expansion of its robust network of brands, client partners, followers and the growing IBN Podcast Series .

Proscia Introduces AI-Powered Quality Control to Accelerate Data-Driven Drug Development

Retrieved on: 
Tuesday, May 17, 2022
Technology, Research, Software, Biotechnology, Health, Pharmaceutical, Data Management, Science, Oncology, Cloud, Digital pathology, Disease, Johns Hopkins School of Medicine, Research, AI, Pathology, Multimedia, Solution, List of life sciences, Automation, Sell Control for Life's Speed, University Medical Center, Melanoma, H&E, COVID-19, Bristol Myers Squibb, University of California, FDA, Efficiency, Pressure, Artifact, University, Technology, Organization, Adoption, Blurry, Charles River Laboratories, Intelligence, University Medical Center Utrecht, Cancer, Diagnosis, Laboratory, Data management, Medical device, Medical imaging, Pharmaceutical industry, Unilab

Proscia , a leader in digital and computational pathology solutions, has introduced an automated quality control application that leverages artificial intelligence to improve quality and efficiency in data-driven drug development.

Key Points: 
  • Proscia , a leader in digital and computational pathology solutions, has introduced an automated quality control application that leverages artificial intelligence to improve quality and efficiency in data-driven drug development.
  • In launching automated quality control, Proscia is delivering on digital pathologys first suite of process automation solutions, streamlining manual, repetitive tasks with AI.
  • View the full release here: https://www.businesswire.com/news/home/20220517005410/en/
    Blurry, unreadable regions of an H&E stained slide image are detected and highlighted with Proscia's AI-powered automated quality control.
  • The launch of automated quality control marks the next milestone in Proscias journey to accelerate the adoption of AI in research and diagnostic pathology.

tab32 Hires 135th Employee, Opens East Coast HQ

Retrieved on: 
Tuesday, May 17, 2022
Hotel manager, 135th, PMS, DSO, VP, DSOS, Patient, Voice over IP, Health, Standard Model, Dental, Chief Dental Officer (Canada), University of California, X-ray, Marketing, University, Adoption, SVP, LightWave 3D, Intelligence, Director, Growth, Management, Video game

ROCKLIN, Calif., May 17, 2022 /PRNewswire/ -- tab32, the dental industry's #1 complete cloud-based technology platform, today announced the hiring of its 135th employee – a landmark that coincides with the opening of the company's new East Coast headquarters in downtown Miami. Capping a banner year that saw a series of key executive hires, high-profile DSO customer wins, and 3X year-on-year growth, these achievements position tab32 to accelerate its mission to transform the dental industry.

Key Points: 
  • ROCKLIN, Calif., May 17, 2022 /PRNewswire/ -- tab32 , the dental industry's #1 complete cloud-based technology platform, today announced the hiring of its 135th employee a landmark that coincides with the opening of the company's new East Coast headquarters in downtown Miami.
  • Capping a banner year that saw a series of key executive hires, high-profile DSO customer wins, and 3X year-on-year growth, these achievements position tab32 to accelerate its mission to transform the dental industry.
  • To spearhead tab32's expansion, Daniel Masvidal and Erik Martinez have taken the helm at tab32's new East Coast headquarters in Miami, where they have tripled headcount in just 3 months.
  • The pair are now aggressively recruiting operational talent to bring tab32's technologies to hundreds of dental practices east of the Mississippi.

How to Balance Scientific Complexity With Patient-Centric Clinical Trial Protocol Design, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, May 17, 2022
University of California, CEO, Industry, University, Clinical trial, MD, Doctor of Philosophy, Food, Pharmaceutical industry, Medical imaging, Biostatistics, Epidemiology

TORONTO, May 17, 2022  /PRNewswire-PRWeb/ -- In clinical trials, documents, data and applications are separate with no single source of truth. Imagine a world where a clinical trial protocol design can be done and implemented in days. This vision is becoming a reality with the use of smart templates to build trials and standards-based ontologies linking downstream systems while using data to build real-time patient journeys and budget insights.

Key Points: 
  • In this free webinar, learn how clinical study teams can balance the complexity of modern trial designs with a patient's first mission.
  • Learn how data driven insights can be utilized to proactively identify areas of decentralization during the initial design of the protocol.
  • The featured speakers will discuss the role of modern trial designs and the collaboration done by digital clinical design platforms.
  • For more information, or to register for this event, visit How to Balance Scientific Complexity With Patient-Centric Clinical Trial Protocol Design.

AviadoBio Announces Formation of Scientific Advisory Board

Retrieved on: 
Thursday, May 12, 2022
Neurosurgery, LifeArc, NEA, Dementia, Capital, Ludwig Cancer Research, Ohio State University College of Medicine, Molecular medicine, Radiology, University of California, University, Neuroscientist, Twitter, SAB, FTD, Master of Science, Autosome, Gene, Neurodegeneration, Research, Brain, Board, UMMS, Frontotemporal dementia, Harvard Medical School, Department, Death, Doctor of Philosophy, Language, Amyotrophic lateral sclerosis, University college, Central nervous system, LinkedIn, Massachusetts General Hospital, Coronavirus Scientific Advisory Board (Turkey), ALS, Assistant, GRN, Patient, AAV, WWE Performance Center, DDF, New Enterprise Associates, Journal of Cellular and Molecular Medicine, Diagnosis, CEO, Pharmaceutical industry, Vaccine, Management, MD, Neurology, Neuroscience

Includes prominent international scientific and clinical pioneers across neurodegeneration research, neurosurgical drug delivery and neurological gene therapy

Key Points: 
  • Includes prominent international scientific and clinical pioneers across neurodegeneration research, neurosurgical drug delivery and neurological gene therapy
    London, UK, May 12, 2022 AviadoBio, a pioneering, pre-clinical stage, gene therapy company focused on developing and delivering transformative medicines for people with neurodegenerative disorders, announces that it has established a Scientific Advisory Board (SAB) comprising world-leading experts in neurodegenerative diseases, neurosurgical drug delivery and gene therapy development.
  • Lisa Deschamps, CEO of AviadoBio, said: "Attracting such an esteemed and diverse group of neurodegenerative disease, neurosurgery and gene therapy experts to the AviadoBio team is a testament to the strength of our differentiated approach.
  • Professor Chris Shaw, commented: I am delighted to Chair AviadoBios Scientific Advisory Board, which includes world-leading experts in their respective fields.
  • For more information, please visit www.aviadobio.com and follow us at Twitter @AviadoBio and LinkedIn AviadoBio.